This program will address various legal, regulatory, and policy hurdles for health care businesses that venture into social media advertising and marketing, including relationships between health care providers and social media influencers. Nixon Peabody’s national health care and entertainment team will address key issues facing innovative digital health companies and traditional health care providers when engaging in online and social media marketing.
Our discussion will cover:
• fraud and abuse restrictions on referrals, including the federal Anti-Kickback Statute and the Stark Law;
• truth-in-advertising laws, including guidance from the Federal Trade Commission;
• state laws impacting advertising of physician services;
• evolving policies from social media companies, including Facebook’s recent changes to its policies around prescription drug advertising for online pharmacies, telehealth providers, and pharmaceutical manufacturers; and
• key considerations for content creators and influencers using these platforms to market health care services and products.
AI agents — autonomous systems capable of planning, deciding, and acting independently across ...
This course examines the latest legal and compliance developments in the artificial intelligence (AI...
Trial Starts Now: Winning the Final Six Months provides a comprehensive guide to the critical tasks ...
Discussion of religion and reasonable accommodation in the workplace. Thanks to the United States Su...
Estate planning for LGBTQ+ clients and families formed through assisted reproductive technology requ...
This CLE course will provide critical insight to counsel for insurers facing bad faith claims on how...
During this course, you will learn about best practices and strategies for retaining intellectual pr...
For at least the last half-century, the success or failure of most litigations is determined by how ...
This dynamic CLE presentation challenges trial lawyers to rethink everything they were taught about ...
Class action litigation continues to evolve rapidly in response to an innovative plaintiffs’ b...